Publications by authors named "Axel LeCesne"

Claim this Profile
L
Low-Grade Uterine Leiomyosarcoma Is Highly Sensitive to Hormonal Treatment.
Roberta Sanfilippo, Marta Sbaraglia, Chiara Fabbroni, Sabrina Croce, Isabelle Ray-Coquard, Axel Lecesne

Clin Cancer Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mutation in metastatic colorectal cancer: a new target.
Rebecca Ibrahim, Khalil Saleh, Claude Chahine, Rita Khoury, Nadine Khalife, Axel Lecesne

Future Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Resistance to Antibody-Drug Conjugates.
Rita Khoury, Khalil Saleh, Nadine Khalife, Mohamad Saleh, Claude Chahine, Axel Lecesne

Int J Mol Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival of soft tissue sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an EORTC-STBSG database study.
Arie Jan Verschoor, Saskia Litière, Sandrine Marréaud, Ian Judson, Maud Toulmonde, Axel LeCesne

Clin Sarcoma Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'.
Patrick Schöffski, Olivier Mir, Bernd Kasper, Zsuzsanna Papai, Jean-Yves Blay, Axel LeCesne

Eur J Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.
Silvia Stacchiotti, Stefano Ferrari, Andres Redondo, Nadia Hindi, Emanuela Palmerini, Axel LeCesne

Lancet Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distal extremities soft tissue sarcomas: Are they so different from other limb localizations?
Jean-Camille Mattei, Véronique Brouste, Philippe Terrier, Sylvie Bonvalot, Axel Lecesne

J Surg Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial.
Javier Martin-Broto, Silvia Stacchiotti, Antonio Lopez-Pousa, Andres Redondo, Daniel Bernabeu, Axel LeCesne

Lancet Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO).
Loïc Chaigneau, Anna Patrikidou, Isabelle Ray-Coquard, Thibaud Valentin, Claude Linassier, Axel Lecesne

Oncologist· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interventional radiology: Role in the treatment of sarcomas.
Thierry de Baere, Lambros Tselikas, Guillaume Gravel, Antoine Hakime, Frederic Deschamps, Axel Lecesne

Eur J Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer.
Alexandre Ivagnès, Meriem Messaoudene, Gautier Stoll, Bertrand Routy, Aurélie Fluckiger, Axel LeCesne

Oncoimmunology· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline /P16INK4A mutations contribute to genetic determinism of sarcoma.
Fanélie Jouenne, Isaure Chauvot de Beauchene, Emeline Bollaert, Marie-Françoise Avril, Olivier Caron, Axel Lecesne

J Med Genet· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone.
Czar Louie Gaston, Robert J Grimer, Michael Parry, Silvia Stacchiotti, Angelo Paolo Dei Tos, Axel LeCesne

Clin Sarcoma Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-α by restoring p53 function.
Jane Muret, Meriem Hasmim, Izabela Stasik, Abdelali Jalil, Aude Mallavialle, Axel Lecesne

PLoS One· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors.
Nicolas F Delahaye, Sylvie Rusakiewicz, Isabelle Martins, Cédric Ménard, Stephan Roux, Axel Lecesne

Nat Med· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophosphamide induces differentiation of Th17 cells in cancer patients.
Sophie Viaud, Caroline Flament, Mustapha Zoubir, Patricia Pautier, Axel LeCesne

Cancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and pharmacogenetics of imatinib in children and adults.
Aurélie Petain, Darouna Kattygnarath, Julie Azard, Etienne Chatelut, Catherine Delbaldo, Axel LeCesne

Clin Cancer Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
François Ghiringhelli, Cédric Ménard, Magali Terme, Caroline Flament, Julien Taieb, Axel Lecesne

J Exp Med· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.
Jaap Verweij, Paolo G Casali, John Zalcberg, Axel LeCesne, Peter Reichardt

Lancet· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis